Rafferty Asset Management
LGND icon

Rafferty Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Rafferty Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Buy
+801
New +$189K ﹤0.01% 1049
2026
Q1 		– Sell
-1,270
Closed -$240K – 1110
2025
Q4 		$240K Sell
1,270
-33
-3% -$6.34K ﹤0.01% 1040
2025
Q3 		$231K Buy
+1,303
New +$194K ﹤0.01% 1045
2022
Q4 		– Sell
-58,237
Closed -$3.13M – 1136
2022
Q3 		$3.13M Buy
58,237
+13,327
+30% +$783K 0.03% 408
2022
Q2 		$2.5M Sell
44,910
-31,745
-41% -$1.8M 0.02% 421
2022
Q1 		$5.38M Buy
76,655
+17,932
+31% +$1.3M 0.03% 374
2021
Q4 		$5.66M Buy
58,723
+22,229
+61% +$2.05M 0.03% 337
2021
Q3 		$3.17M Buy
36,494
+2,669
+8% +$206K 0.02% 446
2021
Q2 		$2.77M Buy
33,825
+1,417
+4% +$118K 0.02% 533
2021
Q1 		$3.08M Buy
32,408
+16,312
+101% +$1.54M 0.02% 470
2020
Q4 		$999K Sell
16,096
-15,158
-48% -$864K 0.01% 493
2020
Q3 		$1.86M Buy
31,254
+16,037
+105% +$1.09M 0.02% 440
2020
Q2 		$1.06M Buy
15,217
+8,242
+118% +$523K 0.02% 527
2020
Q1 		$316K Sell
6,975
-52,334
-88% -$2.97M 0.01% 422
2019
Q4 		$3.86M Sell
59,309
-47,335
-44% -$3.16M 0.06% 171
2019
Q3 		$6.62M Buy
106,644
+29,128
+38% +$1.83M 0.1% 111
2019
Q2 		$5.52M Buy
77,516
+2,468
+3% +$182K 0.1% 140
2019
Q1 		$5.88M Buy
+75,048
New +$5.69M 0.09% 112

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rafferty Asset Management's LGND Position: Q2 2026 in Review

Rafferty Asset Management opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 801 shares worth $253K. The stake represents ﹤0.01% of the portfolio and ranks #1049 among its holdings. This is a return to the name: Rafferty Asset Management previously reported a position in LGND as recently as Q4 2025.

Rafferty Asset Management first reported a position in LGND in Q1 2019 and has held it in 18 quarters since. The position peaked at $6.62M in Q3 2019. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Rafferty Asset Management held 801 shares of Ligand Pharmaceuticals worth $253K as of Q2 2026.
  • Ligand Pharmaceuticals was a new Rafferty Asset Management position in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #1049 holding.
  • Rafferty Asset Management first reported a position in Ligand Pharmaceuticals in Q1 2019 and has held it in 18 quarters since.
  • Rafferty Asset Management's Ligand Pharmaceuticals position peaked at $6.62M in Q3 2019.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.